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DOI 10.1186/s12891-015-0556-8RESEARCH ARTICLE Open AccessEffect of preoperative neuromuscular training
(NEMEX-TJR) on functional outcome after total
knee replacement: an assessor-blinded randomized
controlled trial
Erika O Huber1,2,3*, Ewa M Roos4, André Meichtry2, Rob A de Bie3 and Heike A Bischoff-Ferrari1,5Abstract
Background: Improving functional status preoperatively through exercise may improve postoperative outcome.
Previous knowledge on preoperative exercise in knee osteoarthritis is insufficient. The aim of the study was to
compare the difference in change between groups in lower extremity function from baseline to 3 months after
Total Knee Replacement (TKR) following a neuromuscular exercise programme (NEMEX-TJR) plus a knee school
educational package (KS) or KS alone.
Methods: 45 patients (55–83 years, 53% male, waiting for TKR) were randomized to receive a minimum of 8
sessions of NEMEXTJR plus 3 sessions of KS or 3 sessions of KS alone. Function was assessed with the Chair Stand
Test (CST, primary endpoint) and the Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales focusing on
daily living function (ADL) and pain (secondary endpoints). Assessments were performed immediately before and
after the intervention, and at 6 weeks, 3 months and 12 months after surgery by a physiotherapist, blinded to
group allocation.
Results: After intervention before surgery we observed a small improvement for primary and secondary endpoints
in both groups, which did not differ significantly between groups: comparing the exercise to the control group the
treatment effect for the CST was −1.5 seconds (95% CI: −5.3, 2.2), for KOOS ADL and KOOS pain the treatment
effect was 1.3 points (−10.1, 12.8) and −2.3 (−12.4, 7.9) respectively. At 3 months after surgery we observed a small
improvement in the primary endpoint in the control group and a significant improvement in the secondary
endpoints in both exercise and control groups, which did not differ significantly between groups: comparing the
exercise group to the control group the treatment effect in the CST was 2.0 seconds (−1.8, 5.8), for KOOS ADL and
KOOS pain the treatment effect was −4.9 points (−16.3, 6.5) and −3.3 points (−13.5, 6.8) respectively.
Conclusions: A median (IQR) of 10 (8, 14) exercise sessions before surgery showed an additional small but
non-significant improvement in all functional assessments compared to patient education alone. These benefits
were not sustained after TKR. Our trial doesn’t give a conclusive answer to whether additional preoperative exercise
on postoperative functional outcomes is beneficial.
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Osteoarthritis (OA) is the second most common diag-
nosis made in older adults seeking medical care [1] and
the leading cause of disability at older age [2]. For suf-
ferers from severe knee OA, Total Knee Replacement
(TKR) is the preferred treatment option to significantly
improve function and pain [3,4]. Given the growing
segment of the senior population in the Western
World, the rate of these procedures will rise exponen-
tially over the next decade. This will result in high
health-care expenditures, due to an absolute increase in
TKR surgery [5].
Most patients undergoing TKR experience pain-relief
[6,7], but up to 30% of patients continue to have signifi-
cant pain and functional problems after TKR [8-12].
These continuing problems might be addressed through,
(a) fostering postoperative functional recovery by offer-
ing a preoperative exercise program to optimise the pre-
operative functional status of patients awaiting TKR [13]
and (b) modifying patients’ expectations by offering an
educational program before surgery [14].
The most recent review and meta-analysis on pre-
operative exercise on functional recovery after joint
replacement was published in 2012 and included 12
trials [15]. The authors concluded that “preoperative
therapeutic exercise for total joint replacement did not
demonstrate beneficial effects on postoperative func-
tional recovery. However, poor therapeutic validity of
the therapeutic exercise programmes may have ham-
pered potentially beneficial effects”.
Exercise programs should include mixed activities,
including aerobic, strength and proprioceptive exercises
[16]. Sensorimotor deficiencies, in terms of lower limb
muscle weakness and altered muscle activation patterns,
should be addressed specifically [17]. A well-described
exercise programme that addresses these deficiencies, and
previously found to be feasible in OA patients waitlisted
for TKR, is the neuromuscular exercise programme-total
joint replacement (NEMEX-TJR) [18].
Alternatively, patients may have to be better in-
formed and take more responsibility for their care and
need to be prepared for both the surgical procedure
and the recovery period in advance [19]. An educa-
tional program during the waiting period for TKR may
help patients to prepare themselves for their rehabilita-
tion after surgery [20] and modify patients’ preopera-
tive expectations [14].
Objectives
To study the effect of a preoperative neuromuscular train-
ing (NEMEX-TJR) plus knee school educational program
(KS) compared to the KS alone on lower extremity func-
tion and pain in individuals aged 55–90 years on a waiting
list for TKR due to severe knee OA.Hypothesis
Primary endpoint: we hypothesize that patients under-
going the NEMEX-TJR in addition to the KS will be
quicker in performing the Chair Stand Test (perform-
ance test of lower extremity function) compared with
those receiving the KS alone, both when measured im-
mediately after the intervention and 3 months after TKR
surgery.
Secondary endpoints: we hypothesize that patients
undergoing the NEMEX-TJR in addition to the KS will
have a greater improvement in the patient-reported out-
come (PRO) measure KOOS (subscales ADL function
and pain) compared with those receiving the KS alone,
when measured immediately after the intervention as
well as 6 weeks, 3 months and 1 year after TKR surgery.Methods
Study design
The study design was an assessor-blinded random-
ized controlled trial. Outcomes were measured at
baseline (6–12 weeks preoperative), 1 week preopera-
tive, 6 weeks postoperative, 3 months postoperative
and 12 months postoperative, with the primary end-
point being 3 months postoperative. Ethical approval
was granted by the Ethics Committee of the Cantons
Aargau and Solothurn, Switzerland, approval number
2009/12 and the trial is registered with ClinicalTrials.
gov, identifier: NCT00913575.Participants and randomization
Participants were eligible when: they were on a waiting list
for primary TKR at the Cantonal Hospital Olten or the
Cantonal Hospital Aarau and sufficient time existed before
the operation date in order to take at minimum 8 sessions
of the training program; aged 55 to 90 years; understood
German; and lived at home. Originally it was planned to
only include patients aged 60 and above. However, during
the recruitment phase the age was lowered to 55 to in-
crease the number of participants. The Ethics Committee
accepted an amendment under the same approval num-
ber. Exclusion criteria were: revision surgery; history of
inflammatory arthritis; cognitive impairments; absence be-
fore or after surgery; and inability to walk at least 3 meters
with or without a walking aid. Although our last exclusion
criteria defined a low threshold for functionality to be
enrolled in the trial, none of the study participants was
unable to perform the lower extremity tests defined in the
protocol. Recruitment and eligibility assessment were con-
ducted by the orthopaedic surgeon at the time the patient
was placed on the waiting list. Eligible patients were re-
ferred to the study centre (Centre on Aging and Mobility,
University of Zurich) by fax. After confirming their
interest, eligible individuals received detailed participant
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consent was obtained on the day of baseline assessment.
Allocation was concealed and conducted by a study
nurse of the independent randomization centre after
baseline assessment. Participants were randomized using
block allocation with a block size of four from a com-
puter generated list. Allocation to the intervention or
control group was performed by telephone.
Surgical and rehabilitation procedure
All operations were performed by four senior ortho-
paedic surgeons, using a standard anterior skin incision
followed by medial parapatellar arthrotomy, in an effort
to minimize disruption in the medial lymphatic and sa-
phenous nerve branches. The implants used were all a
posterior cruciate ligament-retaining system performed
in a femur first technique with measured femoral sizing
and rotation. The implants were fully cemented using a
second generation sandwich technique.
The post-surgical rehabilitation process followed an
individualised treatment plan. In the acute care hospital,
physiotherapy treatments aimed to improve passive and
active range of motion, to reduce swelling and to im-
prove walking capacity with canes. Patients were dis-
charged after 7–10 days. The post-acute rehabilitation
took place either in an outpatient physiotherapy practice
(ranging from 9–18 treatment sessions) or in an in-
patient rehabilitation clinic (on average 2–3 weeks, cor-
responding to 10–15 treatment days with at least two
treatment sessions per day). At both sites treatments
aimed to improve active range of motion, muscle
strength and activities of daily living, such as walking
capacity and climbing stairs”.
Interventions
Patients of the intervention group attended knee school
preoperatively (starting about 4 weeks before surgery)
and a neuromuscular training program (for 4–12 weeks,
depending on their location on the waiting list for sur-
gery). Patients of the control group attended only the
three sessions of knee school.
The neuromuscular training followed the principles of
neuromuscular and biomechanical training as described in
the neuromuscular training method (neuromuscular exer-
cise programme-total joint replacement, NEMEX-TJR)
[18]. The programme is feasible in patients with severe
hip or knee OA, in terms of safe self-reported pain follow-
ing training, decreased or unchanged pain during the
training period, few joint-specific adverse events, and
achieved progression of training level during the training
period. In a controlled before-and-after study NEMEX-
TJR (mean 12 weeks (SD 5.6) of training) improved self-
reported outcomes (7-20%) and physical function (5-19%)
(p < 0.005) [21]. Between 39% and 61% of knee patientsdisplayed a clinically meaningful improvement (≥15%) in
KOOS subscales through the training.
The training took place in groups under the supervi-
sion of an experienced, specially-trained physiotherapist
and consisted of a 10-minute aerobic warm-up on a sta-
tionary exercise bike, followed by a four-exercise circuit
programme, and finishing with a cool down period of
about 10 minutes.
The key elements of the circuit programme were
stability/postural function, functional alignment, lower-
extremity muscle strength and functional exercises. Each
exercise was performed for 10–15 repetitions and for 2–
3 cycles, with rest between each exercise and cycle. To
allow progression, three levels of difficulty were defined.
Progression was provided by varying the number, direc-
tion and velocity of the movements, by increasing the
load and/or by changing the support surface. Progres-
sion was made when an exercise could be performed
with 15 repetitions and 3 cycles with good neuromuscu-
lar control and good quality of performance (based on
visual inspection by the physiotherapist) and with min-
imal exertion and control of the movement (perceived
by the patient). Training programme documentation in-
cluded the number of training sessions, level of difficulty
per session, pain on a 0 to 10 scale before and after each
session and 24 hours after each session.
The knee school was taught by an experienced and
specially-trained physiotherapist over 3 individual or group
sessions, one session per week, starting about 4 weeks be-
fore the operation. Knee school sessions were separately
organised for participants of the intervention group and
those of the control group to avoid contamination. The
content of the knee school included information on anat-
omy of the knee joint and adjacent functional structures,
recommended activities with prosthesis and post-operative
pain management, and details on the post-operative re-
habilitation phase. Didactical elements included models of
the knee joint and the lower extremity, working sheets,
photos and videos, handouts, PowerPoint presentations
and peer discussions.
A description of the intervention has been published
previously, where the details of the program are de-
scribed in the additional file [22].
Assessment
Outcomes were measured at baseline (6–12 weeks pre-
operative, all measures), 1 week preoperative (after the
intervention, all measures), 6 weeks postoperative (PROs
only), 3 months postoperative (all measures) and 1 year
postoperative (PROs only). A special clinical examination
room with standardized equipment was used to perform
all the measures at all time-points at both sites. Two expe-
rienced physiotherapists (assessors), not working at the re-
cruitment sites and not involved in the neuromuscular
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for the assessments in this study and were blinded to
group allocation. Participants were instructed not to men-
tion the allocation.
Outcomes
The effect of the intervention on lower extremity function
was evaluated by performance tests and by PRO measures.
In the trial registration we chose as primary endpoints the
Chair Stand Test and the KOOS subscales ADL and pain.
During the recruitment phase we made adaptions in our
endpoints for clearer interpretability, keeping only the
Chair Stand Test as primary endpoint. The KOOS sub-
scales became secondary endpoint and all other measures
became additional outcome measures.
Primary outcome measure
The primary outcome is the Chair Stand Test, also known
as the repeated sit-to-stand test. It is commonly used as a
measure of lower extremity strength, balance and reaction
time [23-25]. The time required for five repetitions of
rising from a chair and sitting down again was performed
according to the OsteoArthritis Initiative manual, includ-
ing detailed standardization and instructions (available
from: http://oai.epi-ucsf.org). Patients sat on a standard
chair without armrests. Feet were placed comfortably on
the floor with knees flexed slightly greater than 90 degrees.
Patients were asked to stand up to a fully erect standing
position five times as quickly as possible without using
their hands (arms folded across the chest). Timing with a
stopwatch started on “Go” (after a countdown from 3) and
ended on the fifth stand. After an exercise phase, the test
was performed once. The Chair Stand Test is easy to
perform in clinical practice and has shown excellent
intra- and inter-rater reliability (ICC, 0.89) in patients
with severe hip or knee OA [26]. The Chair Stand Test
was also found to predict disability across populations
accurately [27].
Secondary outcome measure
Secondary outcomes are knee pain and function, assessed
by the KOOS questionnaire. The KOOS is a commonly
used patient-reported outcome with overall acceptable
psychometric properties to evaluate patients with knee in-
jury and knee OA [28], including those having TKR [29].
KOOS contains 5 subscales with a total of 42 items: 1)
pain; 2) other symptoms; 3) function in daily living (ADL);
4) function in sport and recreation (Sport/Rec); and 5)
knee-related quality of life (QOL). Each question receives
a score from 0 to 4 and the scores are transformed to a 0
to 100 score (0 = extreme symptoms, 100 = no symptoms).
Since exercise training is aiming to improve function, we
are particularly interested in the KOOS ADL subscale for
the functional outcome measure.The German version of the KOOS was used in this
trial [30]. The User’s Guide, including scoring instruc-
tions, are available from http://www.koos.nu.
Additional outcome measures
Lower limb function:
KOOS subscales other symptoms, Sport/Rec and QOL,
assessed by the KOOS questionnaire [30]. Isometric muscle
strength of knee flexors and extensors, measured with a
hand-held pull gauge [31,32].The ability to alternate rapidly
between concentric and eccentric work of the extensor
muscles of the hip and knee is impaired in many patients
with knee OA [33]. The ability of rapid alternation between
concentric and eccentric function is measured using max-
imal number of knee-bending in 30 seconds, which is a
valid and reliable test (ICC, 0.96) [34]. Range of Motion is
measured with a long-arm goniometer [35]. Walking speed
is assessed with the 20 m walk test (ICC, 0.93) [26], a reli-
able modification of the short walk test used in many epi-
demiological and clinical studies. The test measures the
time it takes to walk 20 meters at the participant’s usual
walking pace, along with the number of steps that they take
to walk 20 meters [36]. Lower extremity mobility is further
assessed with the Timed Up and Go test, which requires a
person to rise from a standard stair, walk to a line that is 3
meters away, turn 180 degrees, return to the chair and sit
down [37].
Physical activity and health-related quality of life:
Physical activity is measured by the SenseWear armband,
a device for quantifying physical activity in daily life [38,39].
It collects the following data: energy expenditure, average
MET’s, physical activity duration, steps per day and the
physical activity distribution (sedentary, moderate, vigorous
and very vigorous). In addition, physical activity is measured
by 10 activity questions in NHANES III [40], from which
MET values can be calculated [41]. Health-related quality of
life is measured by the generic questionnaire SF-36 [42,43].
General health status is measured by the EuroQoL (EQ-5D,
including EQ-VAS). The EQ-5D is used to complement the
SF-36, allowing health economic evaluation and compari-
son to other knee OA populations [44].
Sample size calculation
The sample size calculation is based on the primary end-
point - the Chair Stand Test. We assume that the mean
difference in change over time between groups is 7.3 sec-
onds (corresponding to means of 8.3 and 1.0, respect-
ively) and the common within-group standard deviation
is 7.3. This effect was selected based on pilot data of an
uncontrolled trial in knee OA patients, assuming that
our control group (without exercise training) would not
improve over time while awaiting TKR. It is also as-
sumed that the effect size is reasonable, in the sense that
an effect of this magnitude could be anticipated in this
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the power has been set at 0.9. In each group 25 patients
are needed. Assuming a drop-out rate of 12%, we will in-
clude 40 patients per group.
Statistical analysis
The data for primary, secondary and additional out-
comes were analysed according to the intention-to-treat
principle, including all randomized individuals. Descrip-
tive statistics were evaluated for patient characteristics.
For baseline between-group comparisons, we performed
the Wilcoxon-RankSum Test for continuous and the
Chi squared test for categorical variables.
For each outcome, we fitted a linear mixed model
(LMM) to the data with time, group and group-time
interaction as fixed effects and subject as a random
intercept. In a primary analysis we adjusted for gender,
BMI and age. Random intercept models are equivalent
to repeated measures ANOVA and take into account the
correlation between repeated measurements. In contrast
to classical repeated measures ANOVA, they can deal
better with missing observations while retaining power.
For the details of the model see Additional file 1.
Our primary interest was in the treatment effects, which
are equivalent to the group-time interactions. Likelihood ra-
tio tests for nested models were performed for model
selection. We controlled for the potential confounding
factors and tested whether age, gender or BMI could be re-
moved from the model. Specific contrasts such as within-
group changes and group-time interactions between specific
time points were estimated. All simultaneous inference pro-
cedures controlled the family-wise error rate of α = 0.05. Re-
sidual analysis was performed to check model assumptions.
All analyses were conducted with R version 2.14.1 soft-
ware [45,46].
Results
From May 2009 to June 2012 a total of 72 patients were
eligible, of those 27 declined participation and 45 pa-
tients were assessed and randomized to the two groups.
The 22 patients in the exercise group and the 23 pa-
tients in the control group were comparable with respect
to age, gender, BMI, time to surgery and baseline assess-
ments without significant differences in any of the base-
line characteristics outlined in Table 1.
Figure 1 shows the flow diagram of patients participat-
ing in this study.
Description of exercise program performance
Progression
The mean training level at the first session was 1.17 (±0.4)
and at the last session 1.40 (±0.6). In total, 28.6% of the
patients increased their training level, 71.4% stayed at the
start level and none deteriorated.Self-reported pain before and after training sessions
The mean self-reported pain on a numerical rating scale
from 0 to 10 was 2.79 (±1.7) immediately before training,
2.8 (±1.7) immediately after training and 3.1 (±1.7) one
day after training. 63.6% of the patients in the exercise
group reported increased pain twenty-four hours after
training (3.4 (±1.6)). One patient had increased pain > 5
and missed the subsequent two sessions of training.
Adherence and joint-specific adverse events
The median number of attended sessions was 10 (IQR: 8,
14). 76.2% of the patients attended the pre-defined goal of
8 or more treatment sessions, while 23.8% attended less.
The reasons for attending less than 8 sessions, were pre-
scheduled surgery or in one patient withdrawal on the day
of the first training session. In total, 231 (82%) of 282 ses-
sions were attended and one patient missed 2 sessions due
to increased pain, which was determined as a joint-specific
adverse event.
Additional objectively assessed physical activity
Besides the NEMEX-TJR, these patients reported an aver-
age activity performance of 17.9 hours per week (74%
ADL activity, 25% endurance and strength, 1% sport).
Treatment effects in the primary and secondary endpoints
After intervention but before surgery
We observed a small improvement for all primary and
secondary endpoints in both exercise and control groups
(see Table 2), which did not differ significantly between
groups. Comparing the exercise to the control group the
treatment effect for the Chair Stand Test was −1.5 sec-
onds (95% CI: −5.3, 2.2), for KOOS ADL and KOOS
pain the treatment effect was 1.3 points (−10.1, 12.8)
and −2.3 (−12.4, 7.9) respectively.
6 weeks after surgery
Comparing the exercise to the control group the treat-
ment effect for KOOS ADL and KOOS pain was −2.0
points (−13.3, 9.3) and −6.4 (−16.5, 3.6) respectively.
Three months after surgery
Comparing the exercise to the control group the treat-
ment effect in the Chair Stand Test was 2.0 seconds
(−1.8, 5.8). For KOOS ADL and KOOS pain the treat-
ment effect was −4.9 points (−16.3, 6.5) and −3.3 points
(−13.5, 6.8) respectively.
12 months after surgery compared to three months after
surgery
Comparing the exercise to the control group the treat-
ment effect for KOOS ADL and KOOS pain was 3.5
points (−8.5, 15.7) and 2.3 (−8.5, 13.0) respectively.
All results are presented in Table 2, Figures 2 and 3.
Table 1 Baseline characteristics of study participants
Intervention
group (n = 22)
Control group
(n = 23)
p-value
Age – years 68.8 ± 8.0 71.9 ± 8.1 0.198
Females (%) 11 (50) 10 (43.5) 0.889
BMI – kg/m2 30.8 ± 4.9 29.9 ± 5.5 0.507
Time to surgery - weeks 8.9 ± 3.6 8.5 ± 3.0 0.790
Primary and secondary
outcome measures
Chair Stand Test 16.3 ± 8.3 16.0 ± 4.7 0.581
KOOS pain 48.1 ± 17.6 47.3 ± 16.8 0.864
KOOS ADL 51.7 ± 17.8 49.9 ± 19.1 0.716
Additional outcome
measures
KOOS symptoms 47.4 ± 13.5 49.1 ± 15.1 0.982
KOOS sport and
recreation
18.3 ± 17.5 16.9 ± 17.6 0.680
KOOS quality of life 26.4 ± 14.5 26.8 ± 15.3 0.900
Muscle strength
Knee extension op 244.8 ± 91.7 247.6 ± 100.5 1.000
Knee extension contra 285.0 ± 97.8 315.4 ± 123.1 0.386
Knee flexion op 165.4 ± 61.9 151.9 ± 53.8 0.447
Knee flexion contra 176.6 ± 65.6 185.4 ± 66.9 0.525
Knee-bendings/30s 13.1 ± 3.9 11.4 ± 5.5 0.406
ROM of the knee
Flexion op 115.7 ± 11.5 115.0 ± 12.0 0.748
Flexion contra 119.5 ± 8.0 122.9 ± 11.5 0.219
Extension op 6.6 ± 4.7 6.7 ± 4.4 0.708
Extension contra 1.6 ± 2.8 3.0 ± 3.9 0.203
20 m walk test 17.6 ± 2.9 17.9 ± 4.8 0.658
Timed up and go 9.7 ± 2.4 11.5 ± 7.2 0.329
Physical activity level
METs (kcal/h/kg) 28.5 ± 4.5 29.3 ± 4.5 0.617
Steps (daily average) 6158.7 ± 3317.4 6145.0 ± 2810.9 0.967
Adapted NHANES III
METs
24.4 ± 23.6 21.2 ± 29.0 0.244
SF 36
Physical functioning 43.4 ± 17.5 44.1 ± 19.1 0.906
Role physical 43.2 ± 45.8 35.2 ± 44.8 0.575
Bodily pain 41.9 ± 15.5 43.7 ± 14.3 0.706
General health 62.6 ± 15.2 64.4 ± 17.4 0.467
Vitality 57.1 ± 20.3 52.3 ± 19.4 0.723
Social functioning 87.5 ± 18.1 83.5 ± 22.6 0.580
Role emotional 77.3 ± 40.4 62.1 ± 47.5 0.305
Mental health 79.5 ± 14.2 73.6 ± 16.6 0.215
EQ-5D
Mobility 1.7 ± 0.5 1.7 ± 0.5 0.755
Self-care 1.0 ± 0.0 1.1 ± 0.4 0.081
Table 1 Baseline characteristics of study participants
(Continued)
Usual Activities 1.4 ± 0.5 1.3 ± 0.5 0.764
Pain/discomfort 2.1 ± 0.4 2.0 ± 0.2 0.335
Anxiety/Depression 1.2 ± 0.4 1.2 ± 0.4 0.724
EQ-VAS 64.6 ± 18.2 67.7 ± 16.0 0.684
RAPT 9.4 ± 1.5 9.4 ± 1.4 0.298
Values are the mean ± SD for continuous variables (Wilcoxon Rank Sum test)
and the number (percentage) for categorical variables (Chi-square test). There
were no significant between group differences for all variables.
Legend:
BMI, body mass index; op, operated leg; contra, contralateral leg; ROM, range
of motion; MET, metabolic equivalent task; KOOS, Knee Injury and
Osteoarthritis Outcome Score; NHANES, National Health And Nutrition
Examination Survey; SF 36, Short Form-36 health survey; EQ-5D, EuroQol – 5
dimensions; EQ-VAS, EuroQol - Visual Analog Scale; RAPT, Risk Assessment and
Prediction Tool.
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At all time-points, comparing the exercise to the control
group we found no significant treatment effect in any
additional outcome measures.
All results are presented in Table 2.
Change within groups
In within groups we observed at 1 week preoperatively a
significant improvement in the isometric muscle strength
of the knee flexors of the operated leg in the exercise
group (23.0 (−4.8, 50.8) and in the range of motion of the
knee extension of the contralateral leg in the control
group (−1.5 (−3.4, 0.5).
At 6 weeks postoperatively a significant improvement
in all KOOS subscales beside symptoms was seen
(KOOS ADL: 16.6 (0.7, 32.5) in the intervention group
and 18.6 (2.9, 34.4) in the control group; KOOS pain:
13.2 (−1.0,27.3.) and 19.6. (5.6, 33.6) respectively; KOOS
Sport/Rec: 38.3 (10.2, 66.3) and 26.1 (−4.7, 56.8) respect-
ively; KOOS QOL: 25.5 (7.9, 43.1) and 19.4 (1.7, 37.2)
respectively) as well as in some dimensions of the SF 36
(bodily pain: 15.8 (−1.0, 32.5) and 13.0 (−3.9, 29.8) re-
spectively; general health: 11.2 (−1.4, 23.9) in the inter-
vention group) and in EQ-5D mobility (−0.4 (−0.9, 0.1)
and −0.4 (−0.9, 0.1) respectively).
At 3 months postoperatively we identified in both
groups a significant improvement in all KOOS subscales
beside symptoms in the control group (KOOS ADL (24.0
(8.1, 39.9) and 28.9 (12.9, 44.9) respectively; KOOS pain:
23.4, (9.3, 37.5) and 26.7 (12.5, 40.9) respectively; KOOS
Sport/Rec: 35.7 (7.2, 64.2) and 34.7 (4.9, 64.6) respectively;
KOOS QOL: 32.6 (15.0, 50.2) and 38.5 (20.8, 56.2) respect-
ively; KOOS symptoms: 9.9 (−3.5, 23.3) in the intervention
group), as well as in some dimensions of the SF-36 (phys-
ical functioning: 22.4 (5.3, 39.4) and 29.0 (11.5, 46.4) re-
spectively; bodily pain: 24.5 (7.8, 41.2) and 27.9 (10.8, 45.0)
respectively; general health: 11.8 (−0.8, 24.5) and 14.7 (1.8,
27.6) respectively; role physical: 31.2 (−9.9, 72.2) in the
72 patients passed the
pre-assessment by the 
surgeon and were eligible 
27 were not included:
• not interested for different
reasons (n=19)
• lack of transportation (n=2)
• preponed operation (n=1)
• ill spouse (n=1)
• still working (n=2)
• acute illness (n=1)
• not reachable by telephone 
(n=1)Randomization
21 underwent pre-operative assessment
0 did not undergo pre-operative assessment
19 underwent pre-operative assessment
2 did not undergo pre-operative assessment
• ill at assessment day (n=2)
21 filled out 6 wks post-op questionnaires
0 did not fill out 6 wks post-op questionnaires
45 underwent 
baseline assessment
21 filled out 6 wks post-op questionnaires
0 did not fill out 6 wks post-op questionnaires
23 were assigned to knee school
21 received allocated intervention 
2 discontinued intervention 
• acute illness (n=2)
22 were assigned to neuromuscular training 
program and knee school
21 received allocated intervention
1 did not undergo intervention
• withdrawn at the day of the first intervention 
session (n=1)  
pre-operative after intervention
6 weeks post-operative
21 underwent 3 months post-op assessment
0 did not undergo 3 months post-op assessment
20 underwent 3 months post-op assessment
1 did not undergo 3 months post-op assessment
• Operation on the low back (n=1)
3 months post-operative
17 filled out 1 year post-op questionnaires
4 did not fill out 1 year post-op questionnaires
• Withdrawn (n=4)
19 filled out 1 year post-op questionnaires
1 did not fill out 1 year post-op questionnaires
• Withdrawn (n=1)
1 year post-operative
Figure 1 Flow diagram. Flow diagram of patients participating in this study.
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group; mental health: 9.5 (−3.5, 22.4) in the control group),
the EQ-5D mobility (−0.5 (−1.0, −0.0) and −0.4 (−0.9, 0.1)
respectively) and the EQ-VAS (13.9 (0.6, 27.1) in the inter-
vention group.
Between 3 and 12 months postoperatively booth groups
improved significantly in KOOS pain (15.2 (−0.0, 30.3)
and 12.9 (−2.0, 27.7) respectively) and the intervention
group improved also significantly in SF 36 bodily pain
(13.9 (−4.1, 31.9).
All results are presented in Table 3.
Discussion
This randomized, assessor-blinded, controlled trial evalu-
ated the effect of a preoperative neuromuscular training
(NEMEX-TJR) in addition to patient education compared
to patient education alone of patients undergoing TKR onfunctional outcomes at 3 months postoperatively. We
could not confirm our hypothesis that patients undergoing
the NEMEX-TJR have improve in functional outcome at
3 months after surgery. We observed no improvement in
the primary endpoint and a significant improvement in
the secondary endpoints in both exercise and control
groups, which did not differ significantly between groups.
Noticeably, after the intervention but before surgery we
observed a small improvement for all primary and second-
ary endpoints in both exercise and control groups, which
also did not differ significantly between groups.
The programme was well tolerated based on our ad-
verse event assessment and probably offered some bene-
fit to the patients.
After the intervention but before surgery we found a
small and non-significant benefit in favour of the exercise
group. In support, a Danish trial using the same exercise
Table 2 Estimated treatment effects
Baseline to 1 week pre-op Baseline to 6 weeks post-op Baseline to 3 months post-op 3 months to 12 months post-op
Primary endpoint
Chair Stand Test° −1.5 (−5.3, 2.2) Not assessed 2.0 (−1.8, 5.8) Not assessed
Secondary endpoints
KOOS ADL function°° 1.3 (−10.1, 12.8) −2.0 (−13.3, 9.3) −4.9 (−16.3, 6.5) 3.6 (−8.5, 15.7)
KOOS pain°° −2.3 (−12.4, 7.9) −6.4 (−16.5, 3.6) −3.3 (−13.5, 6.8) 2.3 (−8.5, 13.0)
Additional outcomes
Lower limb function
KOOS symptoms°° 2.2 (−7.4, 11.8) 2.4 (−7.2, 11.9) 4.6 (−5.0, 14.2) 3.8 (−6.4, 14.0)
KOOS sport and recreation°° −5.1 (−24.5, 14.4) 12.2 (−8.8, 33.2) 1.0 (-19.9, 21.8) −4.1 (−25.6, 17.5)
KOOS quality of life°° 5.5 (−7.2, 18.1) 6.1 (−6.6, 18.7) −5.9 (−18.5, 6.8) 5.9 (−7.5, 19.3)
Muscle strength (Newton)° Not assessed Not assessed
Knee extension op 8.8 (−40.0, 57.8) −3.5 (−52.7, 45.6)
Knee extension contra 14.2 (−29.8, 58.2) 35.4 (−8.9, 79.4)
Knee flexion op 23.2 (−0.1, 46.5) −12.7 (−36.2, 10.8)
Knee flexion contra 2.0 (−20.8, 24.7) −6.7 (−29.7, 16.2)
Knee-bending/30s° 3.8 (−0.5, 8.0) Not assessed −3.3 (−7.4, 0.8) Not assessed
ROM of the knee (degrees)° Not assessed Not assessed
Flexion op 1.9 (−4.4, 8.2) −3.9 (−10.2, 2.4)
Flexion contra 0.1 (−3.4, 3.7) −1.6 (−5.2, 1.9)
Extension op 0.8 (−2.4, 4.0) 1.4 (−1.8, 4.5)
Extension contra 1.2 (−0.5, 2.8) 1.4 (−0.2, 3.0)
20 m walk test° −0.6 (−2.0, 0.9) Not assessed −0.5 (−2.0, 1.0) Not assessed
Timed up and go° 0.2 (−1.5, 2.0) Not assessed 1.6 (−0.1, 3.3) Not assessed
Physical activity
METs 7 day (kcal/h/kg)° 0.3 (−2.2, 2.7) Not assessed 0.3 (−2.3, 2.9) Not assessed
Steps (daily average)° −687.2 (−2172, 798) Not assessed 165.7 (−1288, 1620) Not assessed
Adapted NHANES III METs° 10.0 (−12.6, 32.7) 1.6 (−20.9, 24.0) 0.4 (−22.3, 23.0) 2.6 (−21.3, 26.4)
Health-related quality of life
SF 36 Physical functioning°° 7.1 (−5.3, 19.5) 0.5 (−11.8, 12.7) −6.6 (−8.5, 17.5) 4.5 (−8.5, 17.5)
Role physical°° −10.8 (−39.9, 18.3) −5.2 (−34.2, 23.9) −3.2 (−32.2, 25.9) −1.1 (−31.7, 29.5)
Bodily pain°° 4.9 (−7.2, 17.0) 2.8 (−9.2, 14.9) −3.4 (−15.5, 8.7) 4.9 (−7.8, 17.7)
General health°° 3.3 (−5.9, 12.4) 3.4 (−5.7, 12.5) −2.8 (−12.0, 6.3) 2.5 (−7.2, 12.1)
Vitality°° −2.3 (−13.9, 9.3) −1.0 (−12.5, 10.5) −8.3 (−20.0, 3.3) 3.3 (−8.9, 15.5.)
Social functioning°° 5.0 (−7.1, 17.2) 2.4 (−9.7, 14.4) −1.6 (-13.7, 10.5) −0.7 (−13.4, 12.1)
Role emotional°° −10.8 (−34.3, 12.7) −11.1 (−34.5, 12.3) −10.2 (−34.0, 13.5) −9.3 (−34.2, 15.7)
Mental health°° 2.6 (−6.6, 11.7) −1.6 (−10.7, 7.5) −3.0 (−12.2, 6.1) 0.4 (−9.2, 10.0)
EQ-5D Mobility°°° 0.1 (−0.3, 0.4) 0.0 (−0.3, 0.4) −0.1 (−0.4, 0.2) 0.1 (−0.3, 0.4)
Self-care°°° −0.0 (−0.2, 2.2) 0.1 (−0.2, 0.3) 0.1 (−0.1, 0.3) 0.0 (−0.2, 0.2)
Usual Activities°°° −0.0 (−0.4, 0.4) −0.1 (−0.5, 0.2) 0.0 (−0.4, 0.4) −0.1 (−0.4, 0.3)
Pain/discomfort°°° −0.1 (−0.4, 0.2) 0.1 (−0.3, 0.4) −0.0 (−0.5, 0.3) −0.1 (−0.4, 0.3)
Anxiety/Depression°°° −0.1 (−0.3, 0.3) 0.0 (−0.2, 0.2) −0.0 (−0.3, 0.3) 0.1 (−0.2, 0.3)
EQ-VAS°° 7.1 (−2.5, 16.7) 2.1 (−7.4, 11.6) 1.2 (−8.4, 10.8) −0.1 (−10.2, 10.0)
Values are differences in mean changes between intervention and control group. Results from a linear mixed model and adjusted for age, gender and BMI.
° Continuous variable (time in seconds, Newton, degree, number, METs, steps).
°° Scores range from 0 to 100 with higher scores indicating fewer problems.
°°° Scores range from 1 to 3 with lower score indicating fewer problems.
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Figure 2 Primary endpoint results. Observed means +/− 1 Standard Error of the Chair Stand Test values for the two groups, at baseline, prior to
surgery and 3 months after surgery. Baseline is treated as outcome, making no assumptions about group differences in the mean response at
baseline, adjusted for age, gender and BMI.
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sions (13 compared to 10) found a moderate and signifi-
cant effect in favour of the exercise group. However this
trial included both hip and knee patients and a sub group
analysis revealed that the improvement in the hip patients
was driving the overall effect [47]. Our results are in line
with a meta-analysis of four trials with 240 participants
[48], which provided moderate quality of evidence that ex-
ercise interventions compared with standard care wereBaseline Pre-op 6 wee
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Figure 3 Secondary endpoint results. Observed means +/− 1 Standard Erro
baseline, prior to surgery, 6 weeks, 3 months and 12 months after surgery.
differences in the mean response at baseline, adjusted for age, gender andeffective in reducing pain from knee osteoarthritis prior to
knee replacement. In addition, our trial showed improve-
ment in performed function which is in disagreement with
the meta-analysis.
At 6 weeks postoperatively we found no between-group
differences in KOOS ADL and pain which is in contrast with
the Danish trial, where the authors found significantly greater
improvements in ADL and pain from exercise [49]. Other
studies showed comparable within group results for pain andks post-op 3 months post-op 12 months post-op
KOOS ADL Intervention
KOOS ADL Control
KOOS pain Intervention
KOOS pain Control
r of the KOOS ADL and KOOS pain scores for the two groups, at
Baseline is treated as outcome, making no assumptions about group
BMI.
Table 3 Estimated within group changes
Baseline to 1 week pre-op Baseline to 6 weeks post-op Baseline to 3 months post-op 3 months to 12 months post-op
Primary endpoint Intervention (n=21) Control (n = 19) Intervention (n = 21) Control (n = 21) Intervention (n = 21) Control (n = 20) Intervention (17) Control (19)
Chair Stand Test° −2.4 (−6.8, 2.1) −0.8 (−5.4, 3.7) not assessed Not assessed 0.3 (−4.3, 4.8) −1.7 (−6.3, 2.9) not assessed not assessed
Secondary endpoints
KOOS ADL function°° 3.7 (−12.2, 19.5) 2.3 (−13.7, 18.3) 16.6 (0.7, 32.5)*** 18.6 (2.9, 34.4)*** 24.0 (8.1, 39.9)**** 28.9 (12.9, 44.9)**** 5.0 (−12.0, 22.1) 1.4 (−15.3, 18.2)
KOOS pain°° 0.8 (−13.3, 14.9) 3.0 (−11.2, 17.2) 13.2 (−1.0, 27.3)** 19.6 (5.6, 33.6)**** 23.4 (9.3, 37.5)**** 26.7 (12.5, 40.9)**** 15.2 (−0.0, 30.3)** 12.9 (−2.0, 27.7)**
Lower limb function
KOOS symptoms°° 1.7 ( −11.7, 15.1) −0.5 (−14.0, 13.0) 7.3 (−6.1, 20.7) 5.0 (−8.3, 18.3) 9.9 (−3.5, 23.3)* 5.2 (−8.2, 18.7) 4.5 (−9.9, 18.9) 0.7 (−13.4, 14.8)
KOOS sport and recreation°° 1.0 (−26.4, 28.4) 6.1 (−20.9, 33.0) 38.3 (10.2, 66.3)**** 26.1 (−4.7, 56.8)* 35.7. (7.2, 64.2)**** 34.7 (4.9, 64.6)**** 8.5 (−21.1, 38.1) 12.5 (−17.9, 43.0)
KOOS quality of life°° 3.8 (−13.8, 21.4) −1.7 (−19.4, 16.0) 25.5 (7.9, 43.1)**** 19.4 (1.7, 37.2)*** 32.6 (15.0, 50.2)**** 38.5 (20.8, 56.2)**** 12.8 (−6.1, 31.7) 6.9 (−11.6, 25.5)
Muscle strength (Newton)° not assessed not assessed not assessed not assessed
Knee extension op 10.2 (−48.0, 68.4) 1.4 (−57.4, 60.3) −47.1 (−106.2, 12.1)* −43.5 (−102.3, 15.3)*
Knee extension contra 14.7 (−22.3, 51.8) 0.6 (−37.0, 38.1) −0.9 (−38.6, 36.9) −36.3 (−73.8, 1.2)
Knee flexion op 23.0 (−4.8, 50.8)* −0.2 (−28.4, 27.9) −20.9 (−49.2, 7.4)* −8.2 (−36.3, 20.0)
Knee flexion contra 9.1 (−18.0, 36.2) 7.1 (−20.4, 34.6) −5.0 (−32.6, 22.7) 1.8 (−25.6, 29.3)
Knee-bending/30s° 2.9 (−2.4, 8.2) −0.9 (−6.0, 4.2) not assessed not assessed 0.4 (−4.6, 5.5) 3.7 (−1.2, 8.7)* not assessed not assessed
ROM of the knee (degrees)° not assessed not assessed not assessed not assessed
Flexion op 2.2. (−5.4, 9.7) 0.2 (−7.4, 7.8) −2.6 (−10.1, 4.9) 1.3 (−6.3, 8.9)
Flexion contra 1.2 (−3.0, 5.4) 1.0 (−3.2, 5.3) 0.9 (−3.3, 5.2) 2.6 (−1.7, 6.8)
Extension op 0.6 (−3.2, 4.3) −0.3 (−4.1, 3.6) −2.7 (−6.4, 1.2) −4.0 (−7.8, −0.2)**
Extension contra −0.4 (−2.3, 1.6) −1.5 (−3.4, 0.5)* −0.7 (−2.6, 1.2) −2.1 (−4.0, −0.2)**
20 m walk test° −0.6 (−2.3, 1.6) −0.0 (−1.8, 1.7) not assessed not assessed −0.9 (−2.6, 0.9) −0.4 (−2.2, 1.3) not assessed not assessed
Timed up and go° −0.6 (−2.6, 1.5) −0.8 (−2.9, 1.3) not assessed not assessed 0.4 (−1.7, 2.5) −1.2 (−3.3, 0.9) not assessed not assessed
Physical activity
METs 7 day (kcal/h/kg) 0.8 (−2.4, 3.4) 0.5 (−2.4, 3.4) not assessed not assessed 1.1 (−1.7, 3.9) 0.5 (−2.4, 3.5) not assessed not assessed
Steps (daily average) −127.5 (−1932, 1677) 559.8 (−1201, 2321) not assessed not assessed −130.3 (−1815, 1554) −296.0 (−2103, 1512) not assessed not assessed
Adapted NHANES III METs 5.1 (−26.6, 36.9) −4.9 (−36.4, 26.6) −8.5 (−40.2, 23.3) −10.1 (−41.1, 21.0) 6.5 (−25.3, 38.2) 6.2 (−25.4, 37.6) 12.2 (−21.5, 45.9) 9.6 (−23.4, 42.6)
Health-related quality
of life
SF 36 Physical functioning°° 2.4 (−14.8, 19.4) −4.7 (−22.2, 12.7) 10.2 (−6.9, 27.3) 9.8 (−7.4, 27.0) 22.4 (5.3, 39.4)**** 29.0 (11.5, 46.4)**** 5.0 (−13.3, 23.4) 0.5 (−17.5, 18.5)
Role physical°° −6.5 (−46.7, 33.6) 4.3 (−36.7, 45.3) −4.1 (−44.3, 36.0) 1.0 (−40.0, 42.0) 28.0 (−12.1, 68.2) 31.2 (−9.9, 72.2)* 3.8 (−39.4, 47.0) 4.9 (−37.4, 47.2)
Bodily pain°° 1.6 (−15.1, 18.3) −3.3 (−20.4, 13.8) 15.8 (−1.0, 32.5)** 13.0 (−3.9, 29.8)* 24.5 (7.8, 41.2)**** 27.9 (10.8, 45.0)**** 13.9 (−4.1, 31.9)* 9.0 (−8.6, 26.6)
General health°° 6.7 (−6.0, 19.3) 3.4 (−9.6, 16.3) 11.2 (−1.4, 23.9)** 7.8 (−4.9, 20.5) 11.8 (−0.8, 24.5)** 14.7 (1.8, 27.6)*** −4.2 (−17.7, 9.3) −6.6 (−19.9, 6.6)
Vitality°° 0.1 (−16.0, 16.1) 2.4 (−14.0, 18.8) 3.0 (−13.1, 19.0) 3.9 (−12.2, 20.1) 5.6 (−10.4, 21.6) 13.9 (−2.5, 30.3)* 4.0 (−13.2, 21.2) 0.7 (−16.2, 17.6)
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Table 3 Estimated within group changes (Continued)
Social functioning°° 2.5 (−14.2, 19.3) −2.5 (−19.6, 14.6) 4.3 (−12.4, 21.1) 2.0 (−14.9, 18.8) 6.7 (−10.1, 23.4) 8.3 (−8.8, 25.4) −0.7 (−18.7, 17.4) 0.0 (−17.6, 17.7)
Role emotional°° 3.9 (−28.6, 36.5) 14.7 (−18.5, 48.0) −2.4 (−35.0, 30.1) 8.7 (−24.1, 41.4) 5.5 (−27.0, 38.1) 15.7 (−18.1, 50.0) −1.5 (−36.5, 33.4) 7.7 (−27.1, 42.5)
Mental health°° 1.3 (−11.3, 14.0) −1.3 (−14.2, 11.6) 4.0 (−7.7, 17.5) 6.5 (−6.2, 19.2) 6.4 (−6.2, 19.1) 9.5 (−3.5, 22.4)* −1.0 (−14.6, 12.5) −1.4 (−14.7, 11.9)
EQ-5D Mobility°°° −0.1 (−0.5, 0.4) −0.1 (−0.6, 0.3) −0.4 (−0.9, 0.1)** −0.4 (−0.9, 0.05)** −0.5 (−1.0, −0.0)*** −0.4 (−0.9, 0.1)* −0.1 (−0.6, 0.4) −0.2 (−0.7, 0.3)
Self-care°°° 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.4) 0.0 (−0.3, 0.3) −0.0 (−0.3, 0.3) −0.1 (−0.4, 0.2) −0.0 (−0.3, 0.3) −0.0 (−0.3, 0.3)
Usual Activities°°° 0.0 (−0.4, 0.6) 0.0 (−0.4, 0.6) 0.0 (−0.4, 0.6) 0.0 (−0.3, 0.7) −0.0 (−0.7, 0.3) −0.0 (−0.7, 0.3) −0.0 (−0.6, 0.4) −0.0 (−0.6, 0.5)
Pain/discomfort°°° 0.0 (−0.4, 0.5) 0.1 (−0.4, 0.6) −0.2 (−0.6, 0.3) −0.3 (−0.7, 0.2) −0.3 (−0.7, 0.2) −0.3 (−0.7, 0.2) −0.3 (−0.8, 0.2) −0.2 (−0.7, 0.2)
Anxiety/Depression°°° −0.0 (−0.3, 0.3) 0.0 (−0.3, 0.4) −0.0 (−0.4, 0.3) −0.0 (−0.4, 0.2) −0.0 (−0.3, 0.3) 0.0 (−0.3, 0.4) −0.0 (−0.4, 0.3) −0.0 (−0.5, 0.2)
EQ-VAS°° 3.9 (−9.4, 17.1) −3.2 (−16.8, 10.3) 8.1 (−5.1, 21.4) 6.0 (−7.3, 19.4) 13.9 (0.6, 27.1)*** 12.6 (−0.9, 26.2) −1.7 (−16.0, 12.5) −1.6 (−15.6, 12.4)
Results from a linear mixed model and adjusted for age, gender and BMI. Values are the mean (95%CI). CI not containing zero indicate statistical significance.
****p <0.0001 ***p ≤ 0.001 **p ≤ 0.01 *p ≤ 0.05.
°Continuous variable (time in seconds, Newton, degree, number, METS, steps).
°°Scores range from 0 to 100 with higher scores indicating fewer problems.
°°°Scores range from 1 to 3 with lower score indicating fewer problems.
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from preoperative time point through 6–8 week postopera-
tive follow up [50,51].
At 3 months postoperatively (primary endpoint), no add-
itional benefits were seen from the preoperative neuromus-
cular training. This is consistent with the Danish trial where
the faster post-operative improvement in ADL and pain from
exercise was blunted after surgery at 3 months follow-up
[49]. Two other RCTs, evaluating the effect of preoperative
training on post-operative outcome, also reported only
within group changes without between group differences
[52,53]. Interestingly the positive trajectory of self-reported
KOOS ADL scores in both groups does not reflect the non-
improvement or the worsening in the objective CST. Several
studies confirm these results, noting improvement in self-
reported measures but not in performance tests [54-56].
We formulated no hypothesis for 12 months postoperative
because, based on literature, we did not expect a significant
difference between-groups mean changes, since, over the
long term, the effects of exercise and control group on func-
tional performance seem to converge [57]. Yet, we found sig-
nificant within-group improvements in both groups, but no
between-group difference in KOOS pain from 3 months to
12 months postoperatively.
The performance level of our study population with
respect to the Chair Stand Test was similar to other
studies with the same patient group at baseline (16.3 ±
8.3 in our study compared to 14.3 ± 6.8 and 13.5 ± 5.9)
[21,49]. It was therefore unexpected, that Chair Stand
Test performance did not improve significantly in the
exercise group at 3 months compared to baseline. An
explanation might be that patients used the contralateral
leg as a compensation to complete the function task
[58]. Also, the KOOS showed similar results in all five
subscales at baseline compared with other studies of the
same patient population [21,49,59]. 3 months postopera-
tively, we identified statistically significant differences
between groups in KOOS ADL, pain and QOL of 3 – 6
points in favour of the exercise group. The question is
whether this difference at group level calls for the implemen-
tation of preoperative exercise in clinical practice. It is in-
creasingly recognized that minimal important change (MIC)
is dependent on context factors, such as patient characteris-
tics, type of intervention, time to follow-up, dimension evalu-
ated, method applied to calculate the MIC, and cut-off
chosen for the anchor question [60]. As a consequence,
“there is no universal MIC, despite the appeal of the notion”
[60]. Additionally it should be kept in mind that the MIC
can be calculated both at an individual level for use in clinical
decision making, and at a group level for use in research. In
research, hypothesis testing and statistical analysis is used to
determine the result, and in this study the average minimal
important difference (MID) between groups ranged from 3–
6 points. These between-group differences of 3–6 points aregreater than the smallest detectable differences reported on a
group level (1.3-2.4) in the only available study giving these
data relating to the KOOS [61], indicating that the current
study is most probably powered to detect between group dif-
ferences significantly different from zero. It should be kept in
mind, however, that there is a lack of studies stating the
measurement error in terms of the smallest detectable differ-
ence for groups in older patients or those having a TKR.
In our study, four senior orthopaedic surgeons per-
formed all operations, but surgical procedures were not
optimally standardized, which might be a possible cause
of bias. It was also not possible to standardize the re-
habilitation procedure in an optimal form, meaning that
some of the patients were discharged to an inpatient re-
habilitation facility and others were discharged home
and received treatment in an outpatient physiotherapy
practice. That could also be a source of bias.
Our study has several strengths. First, our RCT was con-
ducted according to the CONSORT statement [62,63] with a
rigorous study design, a clinically feasible intervention and
good adherence to the programme. Inclusion criteria were
kept broad to reflect daily clinical practice as far as possible.
Second, the blinding of the assessor was ensured through re-
striction of access to obtained data and patient discretion.
Third, we assessed outcomes over the entire time period
from baseline to 1 week preoperative and 6 weeks, 3 months
and 12 months postoperative respectively. Further, the con-
ducted intervention was safe. Moreover, to control of atten-
tion bias, we offered a knee school for all participants.
There are also some limitations to our trial, including the
relatively small recruited sample size of 45 patients instead
of the planned 80 patients. Because of a change in the reim-
bursement system in the acute care hospitals, a reduction
in preoperative waiting-time occurred during the recruit-
ment phase, thus, our trial is underpowered due to logis-
tical recruitment problems that we had to adapt to.
Additionally, our assumptions made in November 2008 for
calculating the sample size seem, in retrospect, and in the
light of several recently published studies, too optimistic
[21,47]. The presented p-values und confidence intervals in
this study will help the reader to interpret our data realistic-
ally. Further, we assumed that functional status of all pa-
tients was reduced and a chance of improvement plausible.
However, only 16 out of 21 patients started at the lowest
exercise level when starting with the NEMEX-TJR. This
may have been avoided by excluding patients with higher
functional levels. On the other hand the preoperative
KOOS scores of our participants are consistent with the lit-
erature of patients undergoing TRK [21,47,49]. Also, due to
slow recruitment, most training did not take place in
groups and the expected positive effect of group training, in
terms of more effective learning compared with individual
practice sessions, was therefore diminished [64]. Moreover,
the median of completed sessions in our study was 10,
Huber et al. BMC Musculoskeletal Disorders  (2015) 16:101 Page 13 of 14which is at the lower limit in terms of adequate dosage [15]
and only 19% of patients progressed to a more difficult
training level, although self-reported pain seemed not to be
a limiting factor. In comparison to previous studies in the
Scandinavian countries [21,49], very few patients pro-
gressed to more difficult training levels. This may reflect a
cultural difference among patients or therapists in the role
of exercise as osteoarthritis treatment. Delivering a sham
exercise instead of a knee school educational programme
would have been optimal, but was not realistic due to the
difficulty in designing a credible placebo intervention.
Conclusions
Viewed over the entire period from baseline to 12 months
postoperatively, a median (IQR) of 10 (8, 14) exercise ses-
sions (NEMEX-TJR) before surgery showed only a small and
non-significant improvement in all functional assessments
compared to patient education alone. Also, this benefit was
not maintained after surgery.
Out trial doesn’t give a conclusive answer to whether
additional preoperative exercise on postoperative func-
tional outcome is beneficial. However, we acknowledge
the small size of our trial as a limitation that may have
prevented us to document small and sustained benefits.
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